CytoMed Therapeutics Limited (GDTC)
NASDAQ·Healthcare·Biotechnology
$0.90
-8.16%
Mkt Cap $12.44M
No analyst coverage available
We don't have analyst ratings or price target data for CytoMed Therapeutics Limited yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.